Language:
English
In:
Antiviral Research, 2005, Vol.66(2), pp.81-97
Description:
A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.
Keywords:
Anti-Viral Therapy ; Sars-Cov ; Ribavirin ; Medicine ; Biology
ISSN:
0166-3542
E-ISSN:
1872-9096
DOI:
10.1016/j.antiviral.2005.03.002
URL:
View record in ScienceDirect (Access to full text may be restricted)
Bookmarklink
